Loading…

Use of preoperative performance status and hemoglobin concentration to predict overall survival for patients aged ≥75 years after radical cystectomy for treatment of bladder cancer

Background The standard of care for treatment of localized muscle-invasive bladder cancer (MIBC) is radical cystectomy (RC). The patient’s condition may affect management of MIBC, especially for elderly patients with more comorbid conditions and lower performance status. We retrospectively evaluated...

Full description

Saved in:
Bibliographic Details
Published in:International journal of clinical oncology 2016-02, Vol.21 (1), p.139-147
Main Authors: Hara, Takahiko, Matsuyama, Hideyasu, Kamiryo, Yoriaki, Hayashida, Shigeaki, Yamamoto, Norio, Nasu, Takahito, Joko, Keiji, Baba, Yoshikazu, Suga, Akinobu, Yamamoto, Mitsutaka, Aoki, Akihiko, Takai, Kimio, Yoshihiro, Satoru, Konishi, Motohiko, Sakano, Sigeru, Imoto, Katsuhiko, Tei, Yasuhide, Yamaguchi, Shiro, Yano, Seiji
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background The standard of care for treatment of localized muscle-invasive bladder cancer (MIBC) is radical cystectomy (RC). The patient’s condition may affect management of MIBC, especially for elderly patients with more comorbid conditions and lower performance status. We retrospectively evaluated the association between clinicopathological data and outcomes for patients with bladder cancer (BCa) treated by RC. We particularly focused on elderly patients (age ≥75 years) with BCa. Methods We enrolled 254 patients with BCa who underwent RC and urinary diversion with or without pelvic lymph node dissection. We assessed perioperative complications and clinicopathological data affecting overall survival (OS) after RC. Results The incidence of complications was 34.3 %, and that of severe complications (Grade 3–5) was 16.5 %. The elderly group experienced more severe complications ( P  = 0.042). Median follow-up was 43.0 months (range 1.0–155.6). Five-year OS after RC was 62.7 %. OS after RC was no different for patients aged ≥75 and
ISSN:1341-9625
1437-7772
DOI:10.1007/s10147-015-0857-9